Patents by Inventor Kurt C. Gish

Kurt C. Gish has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anti-huLRRC15 antibody drug conjugates and methods for their use
    Patent number: 11045480
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: December 13, 2018
    Date of Patent: June 29, 2021
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Anti-CS1 antibodies and antibody drug conjugates
    Patent number: 10308713
    Abstract: The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
    Type: Grant
    Filed: November 21, 2017
    Date of Patent: June 4, 2019
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Han K. Kim, Louie Naumovski
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20190105328
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20190105329
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 13, 2018
    Publication date: April 11, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20190099431
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: December 11, 2018
    Publication date: April 4, 2019
    Inventors: Kurt C. GISH, Jonathan A. HICKSON, Susan Elizabeth MORGAN-LAPPE, James W. PURCELL
  • Anti-huLRRC15 antibody drug conjugates and methods for their use
    Patent number: 10195209
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: February 5, 2019
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • Anti-huLRRC15 antibody drug conjugates and methods for their use
    Patent number: 10188660
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Grant
    Filed: November 29, 2016
    Date of Patent: January 29, 2019
    Assignees: AbbVie Inc., AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20180222979
    Abstract: The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
    Type: Application
    Filed: November 21, 2017
    Publication date: August 9, 2018
    Inventors: Kurt C. GISH, Han K. Kim, Louie Naumovski
  • Anti-CS1 antibodies and antibody drug conjugates
    Patent number: 10011657
    Abstract: The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: July 3, 2018
    Assignee: AbbVie Biotherapeutics Inc.
    Inventors: Kurt C. Gish, Han K. Kim, Louie Naumovski
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20170151344
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Inventors: Kurt C. GISH, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • ANTI-huLRRC15 ANTIBODY DRUG CONJUGATES AND METHODS FOR THEIR USE
    Publication number: 20170151343
    Abstract: The present disclosure provides antibodies, antibody binding fragments, and antibody drug conjugates that bind human LRRC15, their methods of making, and their uses to treat patients having cancer.
    Type: Application
    Filed: November 29, 2016
    Publication date: June 1, 2017
    Inventors: Kurt C. GISH, Jonathan A. Hickson, Susan Elizabeth Morgan-Lappe, James W. Purcell
  • ANTI-CS1 ANTIBODIES AND ANTIBODY DRUG CONJUGATES
    Publication number: 20160122430
    Abstract: The present disclosure provides antibodies and antibody drug conjugates that bind human CS1 and their uses to treat subjects diagnosed with a plasma cell neoplasm, for example, multiple myeloma.
    Type: Application
    Filed: October 30, 2015
    Publication date: May 5, 2016
    Inventors: Kurt C. Gish, Han K. Kim, Louie Naumovski
  • Compositions against cancer antigen LIV-1 and uses thereof
    Patent number: 8313745
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: November 20, 2012
    Assignee: Abbott Biotherapeutics Corp.
    Inventors: David Mack, Kurt C. Gish
  • COMPOSITIONS AGAINST CANCER ANTIGEN LIV-1 AND USES THEREOF
    Publication number: 20110117013
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: June 8, 2010
    Publication date: May 19, 2011
    Applicant: FACET BIOTECH CORPORATION
    Inventors: David Mack, Kurt C. Gish
  • Compositions Against Cancer Antigen LIV-1 and Uses Thereof
    Publication number: 20100074841
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: November 19, 2009
    Publication date: March 25, 2010
    Applicant: FACET BIOTECH CORPORATION
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • MAMMALIAN CHEMOKINE REAGENTS
    Publication number: 20090191629
    Abstract: Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Application
    Filed: March 11, 2009
    Publication date: July 30, 2009
    Inventors: Wei Wang, Kurt C. Gish, Thomas J. Schall, Alain Vicari, Albert Zlotnik
  • Methods of diagnosis of ovarian cancer, compositions and methods of screening for modulators of ovarian cancer
    Patent number: 7435589
    Abstract: Described herein are genes whose expression are up-regulated or down-regulated in ovarian cancer. Related methods and compositions that can be used for diagnosis and treatment of ovarian cancer are disclosed. Also described herein are methods that can be used to identify modulators of ovarian cancer.
    Type: Grant
    Filed: January 22, 2007
    Date of Patent: October 14, 2008
    Assignee: PDL Biopharma, Inc.
    Inventors: David H. Mack, Kurt C. Gish
  • Compositions Against Cancer Antigen LIV-1 and Uses Thereof
    Publication number: 20080175839
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 24, 2008
    Applicant: Protein Design Labs, Inc.
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • Compositions Against Cancer Antigen Liv-1 and Uses Thereof
    Publication number: 20080171039
    Abstract: Described herein are methods and compositions that can be used for diagnosis and treatment of cancer.
    Type: Application
    Filed: December 21, 2007
    Publication date: July 17, 2008
    Applicant: Protein Design Labs, Inc.
    Inventors: Debbie Law, Kurt C. Gish, Richard Murray, Patricia Culp
  • Chemokine TECK polypeptides
    Patent number: 7279460
    Abstract: Novel chemokines from mammals, reagents related thereto including purified proteins, specific antibodies, and nucleic acids encoding said chemokines. Chemokine receptors are also provided. Methods of using said reagents and diagnostic kits are also provided.
    Type: Grant
    Filed: January 7, 2004
    Date of Patent: October 9, 2007
    Assignee: Schering Corporation
    Inventors: Wei Wang, Kurt C. Gish, Thomas J. Schall, Alain Vicari, Albert Zlotnik